Origin Therapeutics Holdings Inc.

Informe acción DB:U8B

Capitalización de mercado: €979.2k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Origin Therapeutics Holdings Dirección

Dirección controles de criterios 0/4

We currently do not have sufficient information about the CEO.

Información clave

Michael Galego

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEO1.0%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates


CEO

Michael Galego (44 yo)

less than a year

Permanencia

Mr. Michael Galego Serves as Interim CEO of Origin Therapeutics Holdings Inc. Since January 14, 2023. He serves as Director at Origin Therapeutics Holdings Inc. since September 2022. He has been an Observe...